CANCER AND LEUKEMIA GROUP B

这是一份临床癌症继续研究的申请书。 CALGB成员。纽约医院-康奈尔医疗中心联手 北岸大学医院及其附属机构 纪念医院的费尔斯通放射中心，仍然是主要的 科学、临床和管理活动的贡献者 CALGB。这些都体现在我们对科学事务的参与上 和CALGB的程序。领导力活动体现在我们的 对CALGB的行政和科学贡献，以及在我们的试点和 第二阶段计划和我们的出版物。 我们的目标是以合作的方式参与设计和 癌症治疗试验的开展。在这方面，我们将(1) 确定缓解和其他反应的效果、程度和持续时间 对CALGB目前关心的疾病的治疗，(2)研究 自然病史和一些疾病的生物病原体 由CALGB研究并经各种实验疗法修改 方案，(3)促进这些疾病的最佳治疗，(4) 参加CALGB试点第二阶段和多学科试验，(5) 继续保持较高的患者收益水平，并继续改善数据 收集，(6)继续积极参与集体活动，如 它涉及到集团科学和集团管理，特别是 关于集团在过去一年中方向和资源的变化 两年了。

This is an application for continuing research in clinical cancer as a member of CALGB. The New York Hospital-Cornell Medical Center together with its associated institutions, North Shore University Hospital and the Firestone Radiation Center at Memorial Hospital, remains a major contributor to the scientific, clinical and administrative activities of CALGB. These are reflected in our participation in the scientific affairs and programs of CALGB. Leadership activities are reflected in our administrative and scientific contributions to CALGB, and in our pilot and phase II programs and in our publications. Our aims are to participate in a cooperative approach in the design and conduct of therapeutic trials in cancer. In this context, we will (1) determine the effect, extent and duration of remission and other responses to treatment of the diseases currently of concern to CALGB, (2) study the natural history and some of the biologic agents of the diseases investigated by CALGB as modified by various experimental therapeutic regimens, (3) promote the best possible treatment of these disorders, (4) participate in pilot phase II and multidisciplinary trials of CALGB, (5) continue a high level of patient accrual and continue to improve data collection, (6) continue our vigorous participation in Group activities as it pertains to Group science and Group administration with particular reference to change in the Group's orientation and resources in the last two years.